Dr. Eric Klein discusses how IsoPSA works for prostate cancer risk assessment

Video

“IsoPSA is a way of measuring all the different PSA-related proteins in the blood,” says Eric A. Klein, MD.

In this video, Eric A. Klein, MD, provides an overview of the IsoPSA test and how it works. Klein is Emeritus Professor and Chair of the Glickman Urological & Kidney Institute at Cleveland Clinic and Cleveland Clinic Lerner College of Medicine in Cleveland, Ohio.

Related Videos
Bree Duncan, RN, BSN, answers a question during a Zoom video interview
Orange pill bottle with loose pills spilling out | Image Credit: © Antonio Rodriguez - stock.adobe.com
A panel of 5 experts on prostate cancer
A panel of 5 experts on prostate cancer
3d rendered illustration of bladder cancer | Image Credit: © SciePro - stock.adobe.com
Heather L. Huelster, MD, answers a question during a Zoom video interview
3d rendered illustration of kidney cancer | Image Credit: © SciePro - stock.adobe.com
Related Content
Genitourinary system diagram

Advancing Patient Care Through Precision PSMA PET/CT Imaging

December 8th 2023
Article
Urology Times Speaking of Urology® logo

Dr. Kishan highlights findings from the MIRAGE trial in prostate cancer

March 23rd 2023
Podcast

Amar Kishan, MD, highlights findings showing that MRI-guided SBRT is superior to CT-guided SBRT in localized prostate cancer.

Midlantic Urology’s Dr. Dean Laganosky is first US urologist to implant FDA-approved balloon spacer for prostate cancer

Midlantic Urology’s Dr. Dean Laganosky is first US urologist to implant FDA-approved balloon spacer for prostate cancer

December 6th 2023
Article

“This next-generation rectal spacing option is the first of its kind...and has the potential to provide an enhanced degree of protection from the genitourinary and rectal effects of prostate cancer radiation therapy,” said Dr. Laganosky.

Dr. Laviana on decisional regret after prostate cancer treatment

Dr. Laviana on decisional regret after prostate cancer treatment

June 28th 2022
Podcast

“Localized prostate cancer is a very complicated disease space,” says Aaron A. Laviana, MD, MBA.

Paul E. Dato, MD, an expert on prostate cancer

Multidisciplinary Care for Patients With mCRPC

December 4th 2023
Article

In the third article of this series, Paul E. Dato, MD, provides comprehensive insights on the multidisciplinary care of patients with metastatic castration-resistant prostate cancer.

NCCN awards funding to 4 advanced prostate cancer research projects

NCCN awards funding to 4 advanced prostate cancer research projects

November 24th 2023
Article

The research projects are assessing combination therapies in advanced prostate cancer that include the use of relugolix.

© 2023 MJH Life Sciences

All rights reserved.